Navigation Links
PharmaNet Experts to Showcase Bioanalytical Posters at ASMS 2011
Date:5/23/2011

PRINCETON, N.J., May 23, 2011 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that its experts will be sharing a range of innovative bioanalysis solutions, including high resolution mass spectrometry applications, at the ASMS 59th Conference on Mass Spectrometry and Allied Topics in Denver, Colorado from June 5 to June 9. PharmaNet's scientists welcome you to attend their poster sessions throughout the conference.Tuesday June 7Poster 255: On-Cartridge Derivatization for the Determination of Bisphosphonates in Human UrineAuthors: Nicolas Jean, Sylvain Lachance, Nadine Boudreau, Sofi Gagnon-Carignan, Ann LevesquePoster 277: Stability issues and method development of a polar phenolic quaternary amine compound in human plasma by LC/MS/MSAuthors: Valerie Montminy, Nicolas Piquet, Sylvain Lachance, Nadine Boudreau; Ann LevesquePoster 257: Using ICP-MS Detection for Determination of Bismuth in Human Blood and Plasma SamplesAuthors: Nadia Savard, Sebastien Gagne, Francois Viel, Brigitte Pellerin, Nadine BoudreauPoster 258: High Throughput Analysis of Biological Samples Containing Trace Metals with Limited Down Time by ICP-MSAuthors: Sebastien Gagne, Francois Viel, Nadine Boudreau, Sylvain Lachance, Sofi Gagnon-Carignan, Ann LevesquePoster 267: Development and Validation of a Dried Blood Spot Assay for the Determination of Midazolam in Human Whole Blood by LC/MS/MSAuthors: Guy Havard, Marie-Claude Theberge, Nadine Boudreau, Ann LevesquePoster 273: Ultra Low Picograms Determination of a Glucocorticoid in Human PlasmaAuthors: Nadia Smith, Nicolas Jean, Nathalie Pelletier, Sylvain Lachance, Nadine Boudreau, Ann LevesquePoster 272: An Ultrasensitive LC/MS/MS Method for the Determination of Formoterol in Human Plasma at Femtogram LevelAuthors: Isabelle M. Levesque, Francois Viel, Sylvain Lachance, Nadine Boudreau, Ann LevesquePoster 271: Evaluation of Hemolysis Effect during Sample Collection and Handling to Mimic Incurred Samples during LC/MS/MS Method ValidationAuthors: Sebastien Gagne, Sylvain Lachance, Nadine Boudreau, Ann LevesquePoster 268: Analyte and Internal Standard Cross Signal Contributions in Mass Spectrometric Detection and Their Impact on the Quantitation by LC/MSAuthors: Aimin Tan, Isabelle A. Levesque, Isabelle M. Levesque, Francois Viel, Nadine Boudreau, Ann LevesquePoster 269: A Novel Automated LCMSMS Method for the Simultaneous Determination of Levothyroxine (T4) and Liothyronine (T3) in Human SerumAuthors: Gilles Provencher, Francois Viel, Nadine Boudreau, Ann LevesquePoster 270: LC/MS/MS Analysis of Doxercalciferol and its Main Metabilite in Human Plasma at Low Picogram LevelAuthors: Guy Havard, Sylvain Lachance, Nadine Boudreau, Ann LevesqueWednesday June 8Poster 146: A Robust and Selective Method for Two Omega-3 Fatty Acids (Eicosapentanoic Acid and Docosahexaenoic Acid) in Several Matrix SpeciesAuthors: Guy Havard, Nathalie Pelletier, Sylvain Lachance, Nadine Boudreau, Ann Levesque, Farhad Amiri, Bruno Battistini, Tina SampalisThursday June 9Poster 469: Determination of Polypeptides and other Large Molecular Weight Molecules by LC/MS/MSAuthors: Genevieve Emond, Nadia Savard, Simon Bedard, Philippe Belanger, Nancy Lampron, Nathalie Pelletier, Marie-Josee Marcoux, Sylvain Lachance, Nadine Boudreau, Ann LevesqueAbout PharmaNet PharmaNet Development Group, Inc., a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet works for you. For more information, please visit www.PharmaNet.com.

Contact:  Anne-Marie Hess
Phone:   (609) 951-6842
E-mail:   ahess@pharmanet.com


'/>"/>

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. JLL Partners Sells PharmaNet
2. inVentiv Health to Acquire PharmaNet
3. Valerie Palumbo Joins PharmaNet as Senior Vice President, Corporate Quality Assurance
4. PharmaNet Shares Expertise in Drug Development Outsourcing at the 2011 Partnerships in Clinical Trials Conference
5. Dr. Jeffrey Freitag Appointed Chief Medical Officer of PharmaNet
6. PharmaNet and Anapharm Europe Formally End Joint Venture
7. Catherine Derasp Joins PharmaNet as Vice President, Clinical Operations
8. PharmaNets Technology Investments Translate to Enhanced Client Service in Its Phase I Clinics
9. PharmaNet Launches New Brand Identity at Upcoming Industry Conferences
10. PharmaNet Development Group Announces Observational Research Survey
11. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):